Oddo BHF - Ackermans van Haaren NV (ACKB) Ackermans Van Haaren : Banking on a step-by-step recovery from COVID affected 20H1

Report

Oddo BHF

Thijs Berkelder

Ackermans & Van Haaren : Banking on a step-by-step recovery from COVID affected 20H1

>Facts: step-by-step recovery from COVID pressured H1 - Ackermans & van Haaren will reports its FY20 results on Friday 26 February at 7.00h CET. An analyst conference call will start at 11.00h CET. As usual, main focus will be on the largest subsidiaries of the holding: in marine engineering listed entities CFE & DEME (both 62% owned) and in private banking Bank Delen and Bank Van Breda (both 78.75% owned). Real estate subsidiary Leasinvest already reported its F...

23/02/2021 5 EN

Underlying

Ackermans & van Haaren NV

Ackermans & Van Haaren is an investment company. Co. operates in five sectors: Marine Engineering & Infrastructure, which includes DEME NV, a dredging and marine company; Private Banking, which includes BDM NV - Continentale Verzekeringen NV (ASCO NV), which focuses on marine and industrial insurance via brokers; Real Estate, Leisure & Senior Care, which includes Extensa Group NV, a real estate developer; Energy & Resources, which includes Telemond Group, a supplier to the crane and automotive industry; and Development Capital, which is engaged in ICT and engineering, retail and distribution, real estate development, and media and printing.

See profile

BE0003764785 Euronext Brussels Belgium

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Thijs Berkelder

Other Reports on these Companies

KBC Securities

Dynamic Top Pick List Update April 2024: Adding TINC

We continue our KBC Securities Dynamic Top Pick List with a 50/50 cyclical/defensive selection, but with a focus on value stocks that have been left behind. Defensive segment like holdings are overweight. However, in the Benelux we have a selection of cyclical industrials at cheap valuations that have often underperformed the market. We favour Benelux value stocks as even a mild recession typically hits growth stocks proportionally harder. We notice that some stocks have been hit hard by minor set-backs. These could be more relatively more resilient over FY24 as investors look for left behind ...

April 4, 2024 April 4, 2024 1 EN

ING Financial Markets

Benelux Morning Notes

Ackermans & van Haaren: Delen acquires Box Consultants, doubles AuM in Netherlands. IBA: 2H23 preview. IMCD: Another step in Latin America. Staffing: Dutch period 2 - Feb 24 volume, revenue trends weaker on tougher comps

March 20, 2024 March 20, 2024 1 EN

KBC Securities

Morning Notes : ABI BB, ACKB BB, IVA FP, IMCD NA

: ABI BB, ACKB BB, IVA FP, IMCD NA

March 20, 2024 March 20, 2024 1 EN

BNP Paribas : Q1 2024 net income to remain impacted by various negative elements, but profitability set to improve by the end of the year

>A slight increase in total revenues expected, but a decline at most business lines - BNP Paribas is due to publish Q1 2024 net income on 25 April 2024. We forecast revenue of € 12,371m (+2.8% vs Q1 2023), beating the consensus (€ 12,199m, +1.4%) despite forecasts in line at the vast majority of business lines, with the difference largely stemming from a more modest decline in revenues at the market activities and corporate center. By business line, we forecast: 1/ re...

4m 4m 1 EN

Anthony Dick ... (+2)

Anthony Dick
Michael Foundoukidis

Forvia : Sometimes no news is good news

>In-line print, enough to be reassuring these days for suppliers - Forvia has reported Q1 2024 sales of € 6,531m, in line with expectations (€ 6,461m) and down 1.7% on a reported basis. This time, no drama like at the full-year release, and a release that contained no bad news and deemed reassuring (notably after Continental earlier). As expected, positive organic growth (+3.1%, an outperformance of 390bp) was more than offset by FX headwinds (-4.2%) and the slightly ...

4m 4m 1 EN

Emmanuel Matot

Emmanuel Matot

Ipsos : Un début d’année freiné par les US

>Croissance organique mitigée au T1 au regard d’une base de comparaison favorable – Déception aux US - Ipsos a publié hier soir son CA au titre du T1 2024. Il s’établit à 558 M€, un niveau en ligne avec les attentes (ODDO/consensus = 555/559 M€). La croissance organique est mitigée (+4.5% vs ODDO/consensus = +5.2/+5%), en accélération par rapport à 2023 (+3.0%) mais à partir d’une base de comparaison favorable (rappel T1 2023 = -2.8%).La zone Amériques affiche un...

4m 4m 1 FR

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN